Llama-derived phage display antibodies in the dissection of the human disease oculopharyngeal muscular dystrophy

Journal of Immunological Methods

Volumn 279, Issue 1-2, 2003, Pages 149-161

  Van Koningsbruggen, S ^a   De Haard, H ^b,d   De Kievit, P ^a   Dirks, R W ^a   Van Remoortere, A ^a   Groot, A J ^a   Van Engelen, B G M ^c   Den Dunnen, J T ^a   Verrips, C T ^b,e   Frants, R R ^a   Van Der Maarel, S M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNILEVER RESEARCH VLAARDINGEN   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d ABLYNX NV   (Belgium)

^e UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Heavy chain antibodies; Immunological applications; Llama; PABPN1; Phage display

Indexed keywords

ALANINE; ANTIBODY; BINDING PROTEIN; GENE PRODUCT; MUTANT PROTEIN; POLY A BINDING PROTEIN NUCLEAR I; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL LINE; CELL STRAIN COS1; CONTROLLED STUDY; ESCHERICHIA COLI; GENE EXPRESSION; GENE SEQUENCE; GOAT; HUMAN; HUMAN CELL; IMMUNIZATION; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; LLAMA; MAMMAL CELL; MUSCLE TISSUE; NONHUMAN; OCULOPHARYNGEAL MUSCULAR DYSTROPHY; OSTEOSARCOMA CELL; PHAGE DISPLAY; PRIORITY JOURNAL; PROKARYOSIS; PROTEIN AGGREGATION;

ESCHERICHIA COLI; LAMA GLAMA; MAMMALIA; PROKARYOTA;

EID: 0142092633     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(03)00232-1     Document Type: Article

References (36)

1. Arbabi G.M., Desmyter A., Wyns L., Hamers R., Muyldermans S. Selection and identification of single domain antibody fragments from camel heavy-chain antibodies. FEBS Lett. 414:1997;521.
2. Better M., Chang C.P., Robinson R.R., Horwitz A.H. Escherichia coli secretion of an active chimeric antibody fragment. Science. 240:1988;1041.
3. Brais B., Bouchard J.P., Xie Y.G., Rochefort D.L., Chretien N., Tome F.M., Lafreniere R.G., Rommens J.M., Uyama E., Nohira O., Blumen S., Korczyn A.D., Heutink P., Mathieu J., Duranceau A., Codere F., Fardeau M., Rouleau G.A., Korcyn A.D. Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy. Nat. Genet. 18:1998;164.
4. Calado A., Tome F.M., Brais B., Rouleau G.A., Kuhn U., Wahle E., Carmo-Fonseca M. Nuclear inclusions in oculopharyngeal muscular dystrophy consist of poly(A) binding protein 2 aggregates which sequester poly(A) RNA. Hum. Mol. Genet. 9:2000;2321.
5. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156.
6. de Haard H.J., van Neer N., Reurs A., Hufton S.E., Roovers R.C., Henderikx P., de Bruine A.P., Arends J.W., Hoogenboom H.R. A large non-immunized human Fab fragment phage library that permits rapid isolation and kinetic analysis of high affinity antibodies. J. Biol. Chem. 274:1999;18218.
7. Deo R.C., Bonanno J.B., Sonenberg N., Burley S.K. Recognition of polyadenylate RNA by the poly(A)-binding protein. Cell. 98:1999;835.
8. Frenken L.G., Hessing J.G., Van den Hondel C.A., Verrips C.T. Recent advances in the large-scale production of antibody fragments using lower eukaryotic microorganisms. Res. Immunol. 149:1998;589.
9. HH antibody fragments and their high level secretion by Saccharomyces cerevisiae. J. Biotechnol. 78:2000;11.
10. Hamers-Casterman C., Atarhouch T., Muyldermans S., Robinson G., Hamers C., Songa E.B., Bendahman N., Hamers R. Naturally occurring antibodies devoid of light chains. Nature. 363:1993;446.
11. Harmsen M.M., Ruuls R.C., Nijman I.J., Niewold T.A., Frenken L.G., de Geus B. Llama heavy-chain V regions consist of at least four distinct subfamilies revealing novel sequence features. Mol. Immunol. 37:2000;579.
12. Hoogenboom H.R., de Bruine A.P., Hufton S.E., Hoet R.M., Arends J.W., Roovers R.C. Antibody phage display technology and its applications. Immunotechnology. 4:1998;1.
13. Hoogenboom H.R., Henderikx P., de Haard H. Creating and engineering human antibodies for immunotherapy. Adv. Drug Deliv. Rev. 31:1998;5.
14. Kohler G., Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 256:1975;495.
15. Krause S., Fakan S., Weis K., Wahle E. Immunodetection of poly(A) binding protein II in the cell nucleus. Exp. Cell Res. 214:1994;75.
16. Kuus-Reichel K., Grauer L.S., Karavodin L.M., Knott C., Krusemeier M., Kay N.E. Will immunogenicity limit the use, efficacy, and future development of therapeutic monoclonal antibodies? Clin. Diagn. Lab. Immunol. 1:1994;365.
17. Liu B., Huang L., Sihlbom C., Burlingame A., Marks J.D. Towards proteome-wide production of monoclonal antibody by phage display. J. Mol. Biol. 315:2002;1063.
18. Marks J.D., Hoogenboom H.R., Bonnert T.P., McCafferty J., Griffiths A.D., Winter G. By-passing immunization. Human antibodies from V-gene libraries displayed on phage. J. Mol. Biol. 222:1991;581.
19. Marks R.S., Margalit A., Bychenko A., Bassis E., Porat N., Dagan R. Development of a chemiluminescent optical fiber immunosensor to detect Streptococcus pneumoniae antipolysaccharide antibodies. Appl. Biochem. Biotechnol. 89:2000;117.
20. Misteli T., Caceres J.F., Spector D.L. The dynamics of a pre-mRNA splicing factor in living cells. Nature. 387:1997;523.
21. Muruganandam A., Tanha J., Narang S., Stanimirovic D. Selection of phage-displayed llama single-domain antibodies that transmigrate across human blood-brain barrier endothelium. FASEB J. 16:2002;240.
22. Muyldermans S. Single domain camel antibodies: current status. J. Biotechnol. 74:2001;277.
23. Muyldermans S., Lauwereys M. Unique single-domain antigen binding fragments derived from naturally occurring camel heavy-chain antibodies. J. Mol. Recognit. 12:1999;131.
24. H domain from naturally occurring camel heavy chain immunoglobulins lacking light chains. Protein Eng. 7:1994;1129.
25. Nguyen V.K., Hamers R., Wyns L., Muyldermans S. Camel heavy-chain antibodies: diverse germline V(H)H and specific mechanisms enlarge the antigen-binding repertoire. EMBO J. 19:2000;921.
26. Sacco-Bubulya P., Spector D.L. Disassembly of interchromatin granule clusters alters the coordination of transcription and pre-mRNA splicing. J. Cell Biol. 156:2002;425.
27. Skerra A., Pluckthun A. Assembly of a functional immunoglobulin Fv fragment in Escherichia coli. Science. 240:1988;1038.
28. Soto C. Protein misfolding and disease; protein refolding and therapy. FEBS Lett. 498:2001;204.
29. Spinelli S., Frenken L.G., Hermans P., Verrips T., Brown K., Tegoni M., Cambillau C. Camelid heavy-chain variable domains provide efficient combining sites to haptens. Biochemistry. 39:2000;1217.
30. Tanha J., Dubuc G., Hirama T., Narang S.A., MacKenzie C.R. Selection by phage display of llama conventional V(H) fragments with heavy chain antibody V(H)H properties. J. Immunol. Methods. 263:2002;97.
31. Uyama E., Tsukahara T., Goto K., Kurano Y., Ogawa M., Kim Y.J., Uchino M., Arahata K. Nuclear accumulation of expanded PABP2 gene product in oculopharyngeal muscular dystrophy. Muscle Nerve. 23:2000;1549.
32. H sequences from conventional and heavy chain antibodies. Mol. Immunol. 34:1997;1121.
33. Wahle E. A novel poly(A)-binding protein acts as a specificity factor in the second phase of messenger RNA polyadenylation. Cell. 66:1991;759.
34. Whitlow M., Bell B.A., Feng S.L., Filpula D., Hardman K.D., Hubert S.L., Rollence M.L., Wood J.F., Schott M.E., Milenic D.E. An improved linker for single-chain Fv with reduced aggregation and enhanced proteolytic stability. Protein Eng. 6:1993;989.
35. Winter G., Milstein C. Man-made antibodies. Nature. 349:1991;293.
36. Winter G., Griffiths A.D., Hawkins R.E., Hoogenboom H.R. Making antibodies by phage display technology. Annu. Rev. Immunol. 12:1994;433.